Visalytics
Visalytics
approved EB-2 (NIW)

Research Fellow

Computational Chemistry · Pakistan · 2025-01-28

Processing Time
66 days
Decision Date
2025-01-28
Location
Singapore
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to design and develop novel molecular structures and computational methods for targeted photothermal therapy and enhanced photoacoustic imaging. This work focuses on improving non-invasive cancer treatments and enhancing diagnostic precision in clinical settings. The endeavor aims to provide more effective treatment options and reduce diagnostic errors within the U.S. healthcare system.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical healthcare needs by improving cancer treatment and diagnostic precision, contributing to U.S. biomedical leadership.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 11 journal articles and 213 citations reflects their influence and capability to advance computational chemistry research.

3 Balance of Interests Met

The high academic and clinical value of the proposed work makes it beneficial for the U.S. to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. and a strong record of 11 peer-reviewed journal articles, 6 conference abstracts, and 1 preprint. These works garnered 213 citations, demonstrating significant influence in the scientific community. The case satisfied all three Dhanasar prongs by showing the national importance of cancer research and the petitioner's strong positioning through scholarly recognition.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Original Contributions

Similar Cases

Physician

Biotechnology · China

WeGreened EB-2 (NIW) approved
27 days 2025-03-13
The petitioner proposes to focus on repurposing existing drugs for cancer treatment by leveraging advanced computational methods and bioinformatics tools. This work aims to enhance therapeutic options, improve patient outcomes, and significantly reduce the time and cost associated with traditional drug development.
View Case

Research Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Indiana 296 days 2025-02-24
The petitioner proposes to develop targeted cancer therapeutics and precision-based therapeutic options to prevent the recurrence of malignant diseases. The work focuses on creating cost-effective, personalized, and immunological therapies to simplify cancer diagnosis and treatment. The endeavor aims to improve treatment outcomes, reduce side effects, and lower long-term healthcare costs in the United States.
View Case

Postdoctoral Researcher

Pharmaceuticals · Bangladesh

WeGreened EB-2 (NIW) approved
Illinois 535 days 2026-01-16
The petitioner proposes to continue research in clinical pharmaceutical sciences, specifically focusing on understanding cancer development at the molecular level. The work involves investigating mechanisms such as genome instability and replication stress to identify actionable molecular targets for cost-conscious therapeutic strategies.
View Case

Others

Research and Development · China

WeGreened EB-2 (NIW) approved
285 days 2025-02-02
The petitioner proposes to develop state-of-the-art machine learning methods for multiscale computational chemistry modeling to support the design and discovery of advanced materials and therapeutics. This work focuses on creating peptide, antibody, and small molecule therapies for treating cancer, obesity, and autoimmune diseases.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from Pakistan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-28.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 66 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Pakistan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist